SynthesisDrug safety2015

Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis.

Alice Capogrosso Sansone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.